Transcode Therapeutics Inc (RNAZ) short interest & short volume · 55K shares short
Transcode Therapeutics Inc official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
RNAZ short interest rose 5.6% to 55K shares in the Oct 15, 2026 report (1.4 days to cover). Daily short volume averaged 47.7% of volume over the last 20 sessions, up from 35.2% the 20 sessions before, the 70th percentile of its own 20-day averages since Sep 23, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 55K
- prior 52K
- % of float
- —
- no float on file
- Days to cover
- 1.4
- avg vol 40K
- Change vs prior report
- +5.6%
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 2)
- 38.9%
- 3K of 9K
- 20-day average
- 47.7%
- prior 35.2%
- Percentile vs own history
- 70th
- 233 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026
Short squeeze score (model)
Price since settlement: -12.8%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
RNAZ's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · RNAZ overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-02 | 3,418 | 8,794 | 38.9% |
| 2026-10-30 | 1,539 | 5,113 | 30.1% |
| 2026-10-29 | 6,758 | 14,008 | 48.2% |
| 2026-10-28 | 2,371 | 3,778 | 62.8% |
| 2026-10-27 | 856 | 5,206 | 16.4% |
| 2026-10-26 | 11,327 | 35,251 | 32.1% |
| 2026-10-23 | 16,680 | 28,315 | 58.9% |
| 2026-10-22 | 11,041 | 15,247 | 72.4% |
| 2026-10-21 | 7,177 | 11,158 | 64.3% |
| 2026-10-20 | 5,243 | 11,338 | 46.2% |
Healthcare peers with similar quant ratings
RNAZ among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- QTTB short interest5.00 · Strong Buy · stock
- AVAH short interest4.99 · Strong Buy · stock
- CDNA short interest4.98 · Strong Buy · stock
- HALO short interest4.97 · Strong Buy · stock
- OSCR short interest4.97 · Strong Buy · stock
- BTSG short interest4.96 · Strong Buy
- REGN short interest4.95 · Strong Buy · stock
- CON short interest4.94 · Strong Buy · stock
RNAZ short interest FAQ
What is RNAZ's short interest?
Transcode Therapeutics Inc (RNAZ) had 55K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report.
How many days to cover does RNAZ have?
1.4 days: 55K shares short divided by an average daily volume of 40K for the Oct 15, 2026 period.
Is RNAZ short interest rising or falling?
RNAZ short interest rose (+5.6%) from 52K to 55K shares in the Oct 15, 2026 report.
Is RNAZ a short squeeze candidate?
Lician's squeeze watch scores RNAZ 5 out of 100 (low) from the Oct 15, 2026 report: days to cover 3.4/25, change in short interest vs prior report 1.7/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of RNAZ daily volume is sold short?
47.7% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 70th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was RNAZ's latest FINRA short volume?
On Nov 2, 2026, cached FINRA short volume for Transcode Therapeutics Inc (RNAZ) was 3,418 shares, 38.9% of 8,794 total volume.
How many RNAZ short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Transcode Therapeutics Inc (RNAZ), from Oct 20, 2026 through Nov 2, 2026.
How did RNAZ short volume percent change from the prior cached session?
Cached FINRA short volume for Transcode Therapeutics Inc (RNAZ) moved from 30.1% on Oct 30, 2026 to 38.9% on Nov 2, 2026, up 8.8 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.